Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-5-5
pubmed:abstractText
Activation of the renal kallikrein-kinin system results in natriuresis and diuresis, suggesting its possible role in renal tubular sodium transport regulation. Here, we used patch-clamp electrophysiology to directly assess the effects of bradykinin (BK) on the epithelial Na(+) channel (ENaC) activity in freshly isolated split-opened murine aldosterone-sensitive distal nephrons (ASDNs). BK acutely inhibits ENaC activity by reducing channel open probability (P(o)) in a dose-dependent and reversible manner. Inhibition of B2 receptors with icatibant (HOE-140) abolished BK actions on ENaC. In contrast, activation of B1 receptors with the selective agonist Lys-des-Arg(9)-BK failed to reproduce BK actions on ENaC. This is consistent with B2 receptors playing a critical role in mediating BK signaling to ENaC. BK has little effect on ENaC P(o) when G(q/11) was inhibited with Gp antagonist 2A. Moreover, inhibition of phospholipase C (PLC) with U73122, but not saturation of cellular cAMP levels with the membrane-permeable nonhydrolysable cAMP analog 8-cpt-cAMP, prevents BK actions on ENaC activity. This argues that BK stimulates B2 receptors with subsequent activation of G(q/11)-PLC signaling cascade to acutely inhibit ENaC activity. Activation of BK signaling acutely depletes apical PI(4,5)P(2) levels. However, inhibition of Ca(2+) pump SERCA of the endoplasmic reticulum with thapsigargin does not prevent BK signaling to ENaC. Furthermore, caffeine, while producing a similar rise in [Ca(2+)](i) as in response to BK stimulation, fails to recapitulate BK actions on ENaC. Therefore, we concluded that BK acutely inhibits ENaC P(o) in mammalian ASDN via stimulation of B2 receptors and following depletion of PI(4,5)P(2), but not increases in [Ca(2+)](i).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-(6-((3-methoxyestra-1,3,5(10)-trie..., http://linkedlifedata.com/resource/pubmed/chemical/8-((4-chlorophenyl)thio)cyclic-3',5'..., http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone, http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Caffeine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP, http://linkedlifedata.com/resource/pubmed/chemical/Epithelial Sodium Channel, http://linkedlifedata.com/resource/pubmed/chemical/Estrenes, http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Protein alpha..., http://linkedlifedata.com/resource/pubmed/chemical/Kallidin, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 4,5-Diphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidinones, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Bradykinin B1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Bradykinin B2, http://linkedlifedata.com/resource/pubmed/chemical/Sarcoplasmic Reticulum..., http://linkedlifedata.com/resource/pubmed/chemical/Sodium, http://linkedlifedata.com/resource/pubmed/chemical/Sodium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Thapsigargin, http://linkedlifedata.com/resource/pubmed/chemical/Thionucleotides, http://linkedlifedata.com/resource/pubmed/chemical/Type C Phospholipases, http://linkedlifedata.com/resource/pubmed/chemical/kallidin, des-Arg(10)-
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1522-1466
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
300
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
F1105-15
pubmed:meshHeading
pubmed-meshheading:21325499-Absorption, pubmed-meshheading:21325499-Aldosterone, pubmed-meshheading:21325499-Animals, pubmed-meshheading:21325499-Biosensing Techniques, pubmed-meshheading:21325499-Bradykinin, pubmed-meshheading:21325499-Caffeine, pubmed-meshheading:21325499-Cyclic AMP, pubmed-meshheading:21325499-Dose-Response Relationship, Drug, pubmed-meshheading:21325499-Epithelial Sodium Channel, pubmed-meshheading:21325499-Estrenes, pubmed-meshheading:21325499-GTP-Binding Protein alpha Subunits, Gq-G11, pubmed-meshheading:21325499-Hydrolysis, pubmed-meshheading:21325499-Ion Channel Gating, pubmed-meshheading:21325499-Kallidin, pubmed-meshheading:21325499-Male, pubmed-meshheading:21325499-Membrane Potentials, pubmed-meshheading:21325499-Mice, pubmed-meshheading:21325499-Mice, Inbred C57BL, pubmed-meshheading:21325499-Natriuresis, pubmed-meshheading:21325499-Nephrons, pubmed-meshheading:21325499-Patch-Clamp Techniques, pubmed-meshheading:21325499-Phosphatidylinositol 4,5-Diphosphate, pubmed-meshheading:21325499-Phosphodiesterase Inhibitors, pubmed-meshheading:21325499-Pyrrolidinones, pubmed-meshheading:21325499-Receptor, Bradykinin B1, pubmed-meshheading:21325499-Receptor, Bradykinin B2, pubmed-meshheading:21325499-Sarcoplasmic Reticulum Calcium-Transporting ATPases, pubmed-meshheading:21325499-Signal Transduction, pubmed-meshheading:21325499-Sodium, pubmed-meshheading:21325499-Sodium Channel Blockers, pubmed-meshheading:21325499-Thapsigargin, pubmed-meshheading:21325499-Thionucleotides, pubmed-meshheading:21325499-Tissue Culture Techniques, pubmed-meshheading:21325499-Type C Phospholipases
pubmed:year
2011
pubmed:articleTitle
Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron.
pubmed:affiliation
Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston, 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural